Company: PTHS
Filing Date: 2025-05-09
Form Type: PREM14C
Source: 0001140361-25-018219
Chunk: 849

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-05-09
Form: PREM14C
Chunk 849
---
OF , each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the date first written above.

| LIGAND PHARMACEUTICALS INCORPORATED |     |        |
| By:                                 |     |        |
|                                     |     | Name:  |
|                                     |     | Title: |

J-18

TABLE OF CONTENTS

IN WITNESS WHEREOF , each Buyer and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the date first written above.

| [OTHER BUYERS] |     |        |
| By:            |     |        |
|                |     | Name:  |
|                |     | Title: |

J-19

TABLE OF CONTENTS

Annex K

| FRANCISCO V. AGUILAR           
 Secretary of State             
 401 North Carson Street        
 Carson City, Nevada 89701-4201 
 (775) 684-5708                 
 Website: www.nvsos.gov         |

| Certificate of Change Pursuant to NRS 78.209 |

TYPE OR PRINT - USE DARK INK ONLY - DO NOT HIGHLIGHT

| INSTRUCTIONS:                                                                                                                                                   
 1.Enter the current name as on file with the Nevada Secretary of State and enter the Entity or Nevada Business Identification Number (NVID).                    
 2.Indicate the current number of authorized shares and par value, if any, and each class or series before the change.                                           
 3.Indicate the number of authorized shares and par value, if any of each class or series after the change.                                                      
 4.Indicate the change of the affected class or series of issued, if any, shares after the change in exchange for each issued share of the same class or series. 
 5.Indicate provisions, if any, regarding fractional shares that are affected by the change.                                                                     
 6.NRS required statement.                                                                                                                                       
 7.This section is optional. If an effective date and time is indicated the date must not be more than 90 days after the date on which the certificate is filed. 
 8.Must be signed by an Officer. Form will be returned if unsigned.                                                                                              |     |                                                                                                                                                                                                                                            |
| 1. Entity information:                                                                                                                                          |     | Name of entity as on file with the Nevada Secretary of State:                                                                                                                                                                              
 Channel Therapeutics Corporation                                                                                                                                                                                                           
 Entity or Nevada Business Identification Number (NVID